Survival prediction of glioblastoma patients using modern deep learning and machine learning techniques
Scientific Reports · 29.01.2024 · 14 (1)
DOI: 10.1038/s41598-024-53006-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 29.01.2024. Verfasst von Samin Babaei Rikan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Engineering, Urmia University, Urmia, Iran. Hauptthemen laut MEDLINE: Glioblastoma, Deep Learning. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this study, we utilized data from the Surveillance, Epidemiology, and End Results (SEER) database to predict the glioblastoma patients’ survival outcomes. To assess dataset skewness and detect feature importance, we applied Pearson's second coefficient test of skewness and the Ordinary Least Squares method, respectively. Using two sampling strategies, holdout and five-fold cross-validation, we developed five machine learning (ML) models alongside a feed-forward deep neural network (DNN) for the multiclass classification and regression prediction of glioblastoma patient survival. After balancing the classification and regression datasets, we obtained 46,340 and 28,573 samples, respectively. Shapley additive explanations (SHAP) were then used to explain the decision-making process of the best model. In both classification and regression tasks, as well as across holdout and cross-validation sampling strategies, the DNN consistently outperformed the ML models. Notably, the accuracy were 90.25% and 90.22% for holdout and five-fold cross-validation, respectively, while the corresponding R 2 values were 0.6565 and 0.6622. SHAP analysis revealed the importance of age at diagnosis as the most influential feature in the DNN's survival predictions. These findings suggest that the DNN holds promise as a practical auxiliary tool for clinicians, aiding them in optimal decision-making concerning the treatment and care trajectories for glioblastoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Computer Engineering, Urmia University, Urmia, Iran.
- SDU Health Informatics and Technology, The Maersk Mc-Kinney Moller Institute, University of Southern Denmark, Odense, Denmark.
- Department of Computer Engineering, Urmia University, Urmia, Iran. j.bagherzadeh@urmia.ac.ir.
- Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands. pirnejad@eshpm.eur.nl.
- Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran. pirnejad@eshpm.eur.nl.
Zitieren
APA
Babaei Rikan, S., Sorayaie Azar, A., Naemi, A., Bagherzadeh Mohasefi, J., Pirnejad, H., & Wiil, U. K. (2024). Survival prediction of glioblastoma patients using modern deep learning and machine learning techniques. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-53006-2
Vancouver
Babaei Rikan S, Sorayaie Azar A, Naemi A, Bagherzadeh Mohasefi J, Pirnejad H, Wiil UK. Survival prediction of glioblastoma patients using modern deep learning and machine learning techniques. Scientific Reports. 2024;14(1). doi:10.1038/s41598-024-53006-2
BibTeX
@article{BabaeiRikan2024,
author = {Babaei Rikan, Samin and Sorayaie Azar, Amir and Naemi, Amin and Bagherzadeh Mohasefi, Jamshid and Pirnejad, Habibollah and Wiil, Uffe Kock},
title = {Survival prediction of glioblastoma patients using modern deep learning and machine learning techniques},
journal = {Scientific Reports},
year = {2024},
volume = {14},
number = {1},
doi = {10.1038/s41598-024-53006-2}
}
EUVIMED